about
Inactivation of Lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loadingControl of RANKL gene expressionOsteoimmunology: interactions of the bone and immune systemNuclear receptors in bone physiology and diseasesCrystal structures of the extracellular domain of LRP6 and its complex with DKK1Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activityParathyroid hormone signaling through low-density lipoprotein-related protein 6Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivoSclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathwayNon-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate.N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling.No association of the polymorphisms of the frizzled-related protein gene with peak bone mineral density in Chinese nuclear familiesGermline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation.Wnt signaling in angiogenesisFunctional and association analysis of frizzled 1 (FZD1) promoter haplotypes with femoral neck geometryInflammation and the osteogenic regulation of vascular calcification: a review and perspective.Wnts' fashion statement: from body stature to dysplasia.Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways.Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation.A positive role of cadherin in Wnt/β-catenin signalling during epithelial-mesenchymal transition.Conditional deletion of gremlin causes a transient increase in bone formation and bone mass.Role of calcitonin gene-related peptide in functional adaptation of the skeleton.HIF-1α inhibits Wnt signaling pathway by activating Sost expression in osteoblasts.Euodia sutchuenensis Dode extract stimulates osteoblast differentiation via Wnt/β-catenin pathway activationWnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1.CD73-generated adenosine promotes osteoblast differentiation.Loading-related regulation of transcription factor EGR2/Krox-20 in bone cells is ERK1/2 protein-mediated and prostaglandin, Wnt signaling pathway-, and insulin-like growth factor-I axis-dependentSclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblastComponents of Intraflagellar Transport Complex A Function Independently of the Cilium to Regulate Canonical Wnt Signaling in Drosophila.Effect of micro-nano-hybrid structured hydroxyapatite bioceramics on osteogenic and cementogenic differentiation of human periodontal ligament stem cell via Wnt signaling pathway.Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During OsteoporosisSerum β -Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis.Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men.
P2860
Q24601727-A9ABC57A-64BB-44F0-A39E-C935008C65FBQ24619669-630CFE5B-201B-4532-A306-1745DD0998AEQ24655113-E2B7A026-37B0-4523-886A-A31E4FBEBC48Q26853017-9C743ED8-810E-4262-916E-9B023AD43E78Q27674857-C4DB0F7D-E9A7-41A7-863E-D07C284F246AQ28510813-C80D5158-BD6B-4647-BFA4-4DAFCC393140Q28567926-DFB1693C-83E4-43F0-B2E2-9DB644E3129BQ28591491-2F13BB39-7815-4B30-AC58-86403EC5EACDQ30497635-495287EA-84BE-4259-A8BE-1A6C0BFD0BC3Q31032805-FCC5C2B7-8855-442B-B2E1-93EDB79A5713Q33436209-BEB6044E-98AD-45F4-B6B4-2A37E1E0E2DDQ33518520-1A79F909-BF09-412A-A948-EA54AAAA956BQ33521540-472D0BFA-9541-4804-A5EE-A55BE53A9905Q33552875-620A66DE-CC98-48B5-AE90-B94712AED62CQ33570529-EE4915D6-0786-4913-B50A-C9E6EDA92931Q33659925-1400EE00-AD2C-40EA-9254-E55B4A50C438Q33693295-2855C9A2-5179-418A-8F1E-3CBD825577D9Q33736936-93ABE57E-77FB-4D54-9DD5-EB4FC8FE468EQ33742267-69904E8E-DE46-4A78-BFFF-FD3967BBC624Q33782750-98FDBE9A-6BC3-4609-B3F8-EA55FCE4993EQ33833409-46C95E64-19CE-44D0-A060-8CC062BCD427Q33864136-BEAA1A57-5DFB-433E-9849-033EFC5F7364Q33926385-10C72317-5B2E-48FA-8E30-A636402442A1Q33985899-F06BEEA8-35EA-4BC2-A6AE-878F4441798FQ34016436-D1562AA9-BB43-4931-9B32-0C09DAF31FD9Q34676851-854833FF-FBF5-4926-94FB-8A9305BFDBCFQ34764595-532FAC25-BA98-4BA0-BE93-2AA649352020Q34776085-F210BD61-1CF5-4F5E-925F-4C9A534287C0Q35152942-51C47837-0331-4F2D-B454-D4E62F80194DQ35156225-48045644-ECEA-44EA-AFF9-86F1B7571814Q35435068-C31523F2-A1BC-4D15-A5AD-B4B20AF2D5DAQ35612746-21EDA3AA-873F-4ACB-87E1-E8E58AD63879Q35763278-D4AB8926-819E-4D44-9861-7AFBD1FDDEF4Q35983181-E4F7AC1B-5D01-4B30-836F-B1FB4AE885CEQ36086488-4EA8CE6A-2972-4125-BC9F-B9FCC87E843AQ36175093-8474E979-CD4E-4017-B3D0-DA3488621B7BQ36288966-54D1BAA9-8AA9-4FA4-BFD6-4259242D08D0Q36756829-584704D1-6275-483E-8F12-3F17342D109FQ36845086-FEAA4D13-D5E2-4DFE-82BA-D028DC9728EBQ36951167-2DE17C16-EF6A-43D3-89FD-6F74E48C2BCE
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Wnt signaling: a key regulator of bone mass.
@ast
Wnt signaling: a key regulator of bone mass.
@en
Wnt signaling: a key regulator of bone mass.
@nl
type
label
Wnt signaling: a key regulator of bone mass.
@ast
Wnt signaling: a key regulator of bone mass.
@en
Wnt signaling: a key regulator of bone mass.
@nl
prefLabel
Wnt signaling: a key regulator of bone mass.
@ast
Wnt signaling: a key regulator of bone mass.
@en
Wnt signaling: a key regulator of bone mass.
@nl
P2093
P1476
Wnt signaling: a key regulator of bone mass.
@en
P2093
Georges Rawadi
Roland Baron
Sergio Roman-Roman
P304
P356
10.1016/S0070-2153(06)76004-5
P577
2006-01-01T00:00:00Z